ENVB
Enveric Biosciences, Inc.Company with tickers: ENVB
CIK
890821
CUSIP
29405E505
Shares Outstanding
3,681,884
13F Activity (30d)
11 filings
11 filers
Price
$2.24
Market Cap
$8.14M
P/E Ratio
-0.06
EPS (Diluted)
$-36.24
52W High
$17.64
52W Low
$1.71
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $345,969 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-1,633,170 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-1,633,473 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-1.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-1.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |